Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk
Launched by APRIL M YOUNG · Dec 9, 2022
Trial Information
Current as of February 05, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This is a Type 1 hybrid effectiveness study involving a community-level, controlled quasi-experimental trial to assess the impact of a community-tailored harm reduction kiosk on HIV, HCV, and overdose risk in rural Appalachia, and a mixed methods evaluation of implementation outcomes. The trial will compare the standard local syringe service program (SSP) design (brick-and-mortar, staffed by department of health staff) to an enhanced model involving a harm reduction kiosk + standard SSP. The kiosk, referred to as the KyOSK (Kentucky Outreach Service Kiosk) will be tailored through a communi...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Individuals are eligible if they are:
- • age 18 or older,
- • live in the intervention or comparison county, and
- • have engaged in injection or non-injection illicit drug use to get high in the past 6 months (excluding marijuana, alcohol, and tobacco).
- Exclusion Criteria:
- Individuals are not eligible if they meet any of the exclusion criteria:
- • being under the age of 18,
- • not living in the intervention or comparison county,
- • having not engaged in injection or non-injection illicit drug use to get high in the past 6 months (excluding marijuana, alcohol, and tobacco),
- • not being able to speak or understand English,
- • conviction in the past 10 years of a violent crime (i.e., murder, manslaughter, rape, robbery, and /or aggravated assault) or stalking,
- • current charges of violent crime or stalking, or
- • having plans to move out of the study counties in the next 6 months, or residing in an inpatient facility.
Trial Officials
April M Young, PhD
Principal Investigator
University of Kentucky
About April M Young
April M. Young is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes. With a focus on innovative therapeutic solutions, the organization collaborates with leading research institutions and healthcare professionals to design and implement rigorous clinical trials. April M. Young prioritizes patient safety and ethical standards, ensuring that all studies are conducted with the utmost integrity. By fostering collaboration and leveraging cutting-edge methodologies, the organization aims to contribute significantly to the scientific community and enhance treatment options across various medical fields.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lexington, Kentucky, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials